Brief Research ReportPublished 27 April 2026Increasing CD4/CD8 ratio confirmed after two years of long-acting cabotegravir and rilpivirine in the SCohoLART studyGabriele Loi · Nicolò Capra · Riccardo Lolatto · Marcella Negri · Gaia Catalano · Flavia Passini · Nicolò Moschetta · Claudia Benelli · Silvia Nozza · Antonella Castagna · Camilla MucciniFrontiers in Virologydoi 10.3389/fviro.2026.1819287